Today’s inauguration of Danisco Shanghai Center gives Danisco a strategic position in one of the world’s biggest centres of growth, Eastern China.
The new centre will combine sales and application laboratories for the entire
group as well as research facilities for its enzyme division Genencor. This US$5
million investment will employ around 100 employees in 5,600 square meters, and
reflects the group’s intent to satisfy the needs of this fast-growing market for
all of its businesses.
‘I’m extremely pleased that we have now
consolidated Danisco’s expertise in Shanghai in one single spot. The centre will
serve as an important springboard for our company’s growth in China and the
nearby region,’ says Tom Knutzen, CEO of Danisco.
Two key aspects of the
new centre located in Hongqiao International Business Park is the opportunity to
work directly with the customers in our application laboratories, and that
Danisco consolidates its enzyme research activities in Asia through its enzyme
division, Genencor.
Genencor is already strongly represented in China
through its renovated manufacturing and applications facilities in Wuxi, outside
Shanghai. ‘Our similar centres in Singapore and France are a great success of
how we as a group can deliver dedicated and tailor-made solutions to our
regional customers, while minimising costs. It therefore felt natural to follow
up on our success by establishing a centre in booming Shanghai, where many of
our customers are located,’ says Tom Knutzen.